BTK Mechanism in B Cells and Beyond; Therapeutic Implications for the Treatment of Immune-Mediated Diseases

Time: 11:30 am
day: Day Two


  • Expression and role of BTK beyond B-cells
  • Key mechanisms of action of BTK for targeting underlying drivers of immunemediated diseases
  • Relating breadth of BTK pharmacology as it relates to the treatment of immunemediated diseases